Novo Holdings acquires biopharma company Paratek for $462m
Paratek’s lead product, Nuzyra, is currently marketed in the US as an oral and intravenous antibiotic.
CymaBay maps out regulatory filing for primary biliary cholangitis drug seladelpar
GSK’s Ojjaara receives FDA approval for treating myelofibrosis patients with anaemia
Signal: Fresh Tracks nears end of operations with plans for dissolution
Alvotech’s AVT05 in Phase III rheumatoid arthritis study, as the sole candidate
Signal: CMR Surgical Raises $165m to continue development of surgical robot
Analysis
View More
Themes
View MoreADDF invest in BrainScope for Alzheimer’s prediction biomarker
The neurotech will receive the investment in Series B equity financing round to invest in Alzheimer’s disease research.
More themes
Premium Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover premium insights powered by our properietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
EMA CHMP recommends approval for Moderna’s updated Covid-19 vaccine
Corporate sustainability needs ESG standards and tools
FDA approves Pfizer-BioNTech’s Omicron XBB.1.5-adapted Covid-19 vaccine
Alexion and Verge enter AI-powered drug discovery deal